Neuromuscular Electrical Stimulation in Critically Ill Patients.

University of Sao Paulo31 enrolled

Overview

The study will investigate the effects of neuromuscular electrical stimulation (NMES) in critically ill patients. The objective of this study will be investigate the effects of neuromuscular electrical stimulation (NMES) in critically ill patients.

The study will investigate the effects of neuromuscular electrical stimulation (NMES) in critically ill patients. It will be a randomised crossover clinical trial. Thirty-one patients will enrolled. Patients will be selected, randomly, to the intervention Protocol (decubitus position with the limbs raised and NMES) and control (decubitus position with the limbs raised without NMES).The patients will be allocated in Group 1 (intervention and control) or group 2 (control and intervention) with a wash-out period of 4 to 6 hours between them. The main outcome will be metabolic data. Linear mixed model will be used for analysis of dependent variables and estimated values of the mean of the differences of each effect. The results of this study will allow better understanding of the metabolic effects of NMES in patients critically ill.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

Conditions

Critical Care Rehabilitation

Interventions

Neuromuscular Electrical StimulationDEVICE

This device produces a muscle contraction in response to a externally generated low-voltage electric impulse, which is conducted through electrodes placed on the skin over the muscle group to be stimulated.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients that will be admitted to the intensive care unit * Hemodynamic stability * Mechanical ventilation. Exclusion Criteria: 1. In general: * a. Pregnant women * b. Brain death * c. Neuromuscular diseases * d. Use of pre-existing neuromuscular blocker in the last 24 hours, prior to the study protocol. 2. Contraindications for the use of NMES: * a. Fractures * b. Burns * c. Skin lesions * d. Systemic vascular impairment diseases such as systemic lupus erythematosus, thromboembolic disease, deep vein thrombosis (which was not therapeutically anticoagulated for a time greater than 36 hours) * e. Lower limb amputations * f. Cardiac pacemaker, * g. Thrombocytopenia less than 20,000/mm3 * h. BMI greater than 35 kg/m2 * i. Important lower extremity oedema * j. Agitation and/or signs of pain during the electrical stimulation. 3. Contraindications to begin or continue NMES procedure: * a. Mean arterial blood pressure less than 65 mmHg * b. Use of vasopressor \>50% of themaximum dose (dopamine \>12.5 μg/kg per minute; vasopressin \>0.02U/min and norepinephrine \>1 μg/kg per minute), * c. Heart rate \<50 or \>140bpm * d. Arrhythmias with hemodynamic consequences * e. Myocardial ischemia, * f. Temperature \<34 or \>39oC * g. Intracranial pressure \>20 cmH2O * h. Decrease in 10% of SpO2 baseline value or \<88% for more than one minute.

Locations (1)

Clinics Hospital

Ribeirão Preto, São Paulo, Brazil

Outcomes

Primary Outcomes

Change of Oxygen consumption (VO2),from baseline and interventions.

Change of Oxygen consumption (VO2) will be evaluated by calorimetry

Time frame: VO2 will be taken during the each intervention, it will be taken only the first day

Secondary Outcomes

Change of Carbon dioxide production (VCO2) from baseline and interventions.

Change of Carbon dioxide production (VCO2) will be evaluated by calorimetry

Time frame: VCO2 will be taken during the each intervention, it will be taken only the first day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.